Catholic University researchers propose new autoimmune disease organoid models

A research team at the Catholic University of Korea has proposed a new strategy for designing organoid models to replicate autoimmune diseases, such as rheumatoid arthritis, lupus, and systemic sclerosis. By combining patient-derived induced pluripotent stem cells (iPSCs) with the patient's actual immune environment—including serum, autoantibodies, and cytokines—the researchers aim to create ‘mini organs’ that more accurately reflect individual disease progression and treatment responses.

Unlike traditional 2D cell cultures or animal testing, which often fail to capture complex human immune responses and individual variations, this approach focuses on the ‘disease-specific microenvironment.’ The strategy suggests integrating organ-on-a-chip technology to simulate blood flow and immune cell movement. This could allow for personalized drug evaluation, the discovery of biomarkers, and the development of alternative testing methods to replace animal experiments.

While the study provides a comprehensive review and design strategy rather than a completed experimental model, it outlines a path toward ‘patient digital twins’ that integrate genetic, immune, and clinical data. Future challenges include improving the maturity of iPSC-derived cells and maintaining the chronic inflammatory environment over long periods.